We are live on
!
Find out more
PM
Parametrica Management Portfolio holdings
AUM
$128M
1-Year Est. Return
171.01%
This Fund
S&P 500
This Quarter
Est. Return
-10.6%
1 Year Est. Return
+171.01%
3 Year Est. Return
+584.07%
5 Year Est. Return
+696.69%
10 Year Est. Return
–
AUM
$135M
AUM Growth
+$34.3M
(+34%)
Cap. Flow
+$49.1M
Cap. Flow
% of AUM
36.36%
Top 10 Holdings %
Top 10 Hldgs %
33.16%
Holding
256
New
198
Increased
7
Reduced
21
Closed
26
Avg Time Held
0.6
quarters
Top 10 Avg Time Held
2
quarters
Top 20 Avg Time Held
1.6
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$7.01M |
| 2 |
State Street SPDR S&P Biotech ETF
XBI
|
+$3.73M |
| 3 |
Li Auto
LI
|
+$3.38M |
| 4 |
Advanced Micro Devices
AMD
|
+$2.48M |
| 5 |
Hertz
HTZ
|
+$2.37M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
United Airlines
UAL
|
+$4.52M |
| 2 |
Meta Platforms (Facebook)
META
|
+$3.71M |
| 3 |
NVIDIA
NVDA
|
+$3.19M |
| 4 |
JetBlue
JBLU
|
+$3.12M |
| 5 |
Norwegian Cruise Line
NCLH
|
+$3.09M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.67% |
| 2 | Technology | 17.49% |
| 3 | Communication Services | 14.87% |
| 4 | Consumer Discretionary | 13.6% |
| 5 | Industrials | 11.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
76
Rogers Corp
ROG
$2.59B
| $392K | 0.29% |
+1,441
| New | +$393K |
2022 Q1
0 quarters
|
|
77
Floor & Decor
FND
$4.78B
| $391K | 0.29% |
+4,833
| New | +$490K |
2022 Q1
0 quarters
|
|
|
MIME
78
DELISTED
Mimecast Limited
MIME
| $391K | 0.29% |
+4,920
| New | +$391K |
2022 Q1
0 quarters
|
|
79
Zoetis
ZTS
$31B
| $388K | 0.29% |
2,060
-261
| -11% | -$51.6K |
2020 Q1
8 quarters
|
|
80
Agilent Technologies
A
$48.5B
| $384K | 0.28% |
+2,902
| New | +$399K |
2022 Q1
0 quarters
|
|
81
Sibanye-Stillwater
SBSW
$6.99B
| $384K | 0.28% |
+23,672
| New | +$384K |
2022 Q1
0 quarters
|
|
82
Upbound Group
UPBD
$895M
| $371K | 0.27% |
+14,747
| New | +$533K |
2022 Q1
0 quarters
|
|
83
Asana
ASAN
$2.29B
| $365K | 0.27% |
+9,139
| New | +$476K |
2022 Q1
0 quarters
|
|
84
Fair Isaac
FICO
$15.6B
| $364K | 0.27% |
+779
| New | +$368K |
2022 Q1
0 quarters
|
|
|
SBNY
85
DELISTED
Signature Bank
SBNY
| $357K | 0.26% |
+1,216
| New | +$395K |
2022 Q1
0 quarters
|
|
86
Caesars Entertainment
CZR
$6.01B
| $356K | 0.26% |
+4,600
| New | +$369K |
2022 Q1
0 quarters
|
|
87
Citigroup
C
$214B
| $354K | 0.26% |
+6,624
| New | +$409K |
2022 Q1
0 quarters
|
|
88
Medifast
MED
$131M
| $351K | 0.26% |
+2,052
| New | +$387K |
2022 Q1
0 quarters
|
|
89
DELISTED
Vonage Holdings Corporation
VG
| $351K | 0.26% |
+17,292
| New | +$354K |
2022 Q1
0 quarters
|
|
|
HZNP
90
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $350K | 0.26% |
+3,325
| New | +$324K |
2022 Q1
0 quarters
|
|
91
NetEase
NTES
$79.7B
| $349K | 0.26% |
+3,899
| New | +$371K |
2022 Q1
0 quarters
|
|
92
Dick's Sporting Goods
DKS
$13.5B
| $345K | 0.26% |
+3,444
| New | +$379K |
2022 Q1
0 quarters
|
|
93
SM Energy
SM
$9.12B
| $345K | 0.26% |
+8,854
| New | +$319K |
2022 Q1
0 quarters
|
|
94
Royalty Pharma
RPRX
$25.2B
| $343K | 0.25% |
+8,808
| New | +$346K |
2022 Q1
0 quarters
|
|
95
CrowdStrike
CRWD
$269B
| $342K | 0.25% |
+6,032
| New | +$281K |
2022 Q1
0 quarters
|
|
96
Synaptics
SYNA
$4.73B
| $341K | 0.25% |
+1,709
| New | +$379K |
2022 Q1
0 quarters
|
|
97
Pool Corp
POOL
$5.77B
| $340K | 0.25% |
+804
| New | +$375K |
2022 Q1
0 quarters
|
|
98
Robert Half
RHI
$3.54B
| $340K | 0.25% |
+2,974
| New | +$343K |
2022 Q1
0 quarters
|
|
99
Asbury Automotive
ABG
$2.94B
| $338K | 0.25% |
+2,045
| New | +$358K |
2022 Q1
0 quarters
|
|
100
Somnigroup International
SGI
$14.5B
| $338K | 0.25% |
+12,105
| New | +$446K |
2022 Q1
0 quarters
|
|
Similar funds
CIS
CWM
NYU
FCU
TLM
RPG
SIA
OCM
Parametrica Management's Q1 2022 Portfolio in Review
As of Q1 2022, Parametrica Management held 256 positions worth $135M, up 34% from $101M the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Parametrica Management deployed $49.1M of net new capital in Q1 2022, opening 198 new positions and adding to 7 existing holdings. Its largest new stake was Pfizer: 135,115 shares worth $7M.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 17% a quarter earlier, followed by Technology and Communication Services.
On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $3.71M trimmed.
- Parametrica Management's largest Q1 2022 buy was Pfizer: 135,115 shares worth $7M.
- Parametrica Management added most to Alphabet (Google) Class A in Q1 2022, an estimated $1.78M increase.
- Parametrica Management's biggest Q1 2022 reduction was Meta Platforms (Facebook), cutting an estimated $3.71M.
- Parametrica Management fully exited United Airlines in Q1 2022, selling an estimated $4.52M.
- Parametrica Management's ten largest holdings make up 33% of its $135M portfolio in Q1 2022.
- Parametrica Management opened 198 new positions and closed 26 in Q1 2022.
- Parametrica Management's portfolio value rose 34% quarter-over-quarter to $135M.
Based on Parametrica Management's 13F filing for Q1 2022, filed 10 May 2022.